Clinical Trials Logo
  1. Home
  2. Circulatory Shock
  3. NCT03483753

Vasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac Surgery — VANCSIII  

Non-cardiac Surgery Clinical Trial

Official title:
Vasopressin or Norepinephrine in Vasoplegic Shock After Non-cardiac Surgery: a Randomized and Controlled Trial

Clinical Trial Summary

The purpose of the present study is to evaluate the effect of vasopressin compared to norepinephrine on the clinical complications of patients with vasospastic shock after noncardiac surgeries.

Clinical Trial Description

The Systemic Inflammatory Response Syndrome (SIRS) is a common complication after non-cardiac surgery, impacting negatively on patient outcome and with high incidence rates. Vasoplegic syndrome is the most serious complication of SIRS and can happen after any type of surgery. The etiology of the vasoplegic syndrome has not yet been fully elucidated, but is known to occur more frequently in patients at high surgical risk, submitted to major surgeries, or in the presence of perioperative complications and patients with comorbidities. In this circumstance, the depletion of vasopressin stocks is described, which may contribute to the refractoriness of the shock and the lack of response to the catecholaminergic drugs. The standard treatment of perioperative vasoplegia has been adequate volume replacement and administration of vasopressors, with norepinephrine being the most commonly used. However, it is known that norepinephrine may have deleterious effects on the body and in 20% of patients with vasospastic shock it is ineffective. Previous studies have suggested benefits of adding vasopressin in refractory situations, especially in septic shock. Recently the VANCS study (Vasopressin or norepinephrine in the vasopregic shock after cardiac surgery: double-blind, controlled and randomized study) demonstrated superiority of vasopressin in the reversion of vasoplegic shock after cardiac surgery, as well as a lower incidence of renal insufficiency, atrial fibrillation and shorter hospitalization time. (Anesthesiology. 2017 Jan;126(1):85-93.) ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03483753
Study type Interventional
Source University of Sao Paulo
Contact
Status Withdrawn
Phase Phase 2/Phase 3
Start date January 2019
Completion date October 2, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03715712 - NORepinephrine-Maintaining-individuaALIZEd Blood Pressure N/A
Recruiting NCT05733208 - The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery N/A
Completed NCT04058769 - Software-guided Guideline Implementation in Premedication N/A
Completed NCT03213496 - Promotion of Ambulation Before Non-cardiac Surgery N/A
Recruiting NCT01758952 - Incidence and Risk Factors of Peri-operative Stroke in Non-cardiac,Non-neurosurgical Surgeries
Not yet recruiting NCT04705064 - Artificial Intelligence and Postoperative Acute Kidney Injury
Active, not recruiting NCT04453722 - Prevention of Opioid-Induced Hypoxemia
Recruiting NCT05242419 - A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery N/A
Completed NCT04843202 - Clinical Guidelines in Premedication Visit
Recruiting NCT05481723 - Lung Ultrasound-guided Hemodynamic Optimization N/A
Active, not recruiting NCT05188001 - Hemodynamics and Myocardial Injury After Non-cardiac Surgery
Not yet recruiting NCT03028389 - Effects of Limb Remote Ischemic Preconditioning for Prevention of Delirium in Elderly Patients After Non-cardiac Surgery N/A
Recruiting NCT04996966 - Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury Phase 1
Completed NCT02743884 - Evaluating Heat Transfer With the Esophageal Cooling Device N/A
Completed NCT01203605 - European Surgical Outcomes Study N/A